| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Forway Investment Ltd.
|
546.803m | 66.12% | — | Dec 31 2024 |
| 2 |
BlackRock Institutional Trust Company, N.A.
|
6.473m | 0.78% | -3.000k | Apr 30 2026 |
| 3 |
Dimensional Fund Advisors, L.P.
|
5.588m | 0.68% | -26.000k | Mar 31 2026 |
| 4 |
The Vanguard Group, Inc.
|
4.759m | 0.58% | -4.086m | Apr 30 2026 |
| 5 |
E Fund Management Co. Ltd.
|
3.161m | 0.38% | +2.408m | Dec 31 2025 |
|
1
Forway Investment Ltd.
|
66.12%
546.803m
|
|
2
BlackRock Institutional Trust Company, N.A.
|
0.78%
6.473m
|
|
3
Dimensional Fund Advisors, L.P.
|
0.68%
5.588m
|
|
4
The Vanguard Group, Inc.
|
0.58%
4.759m
|
|
5
E Fund Management Co. Ltd.
|
0.38%
3.161m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 68.54% of China Shineway Pharmaceutica, with Forway Investment Ltd. the biggest at 66.12%, followed by BlackRock Institutional Trust Company, N.A. (0.78%) and Dimensional Fund Advisors, L.P. (0.68%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


